Quest Diagnostics Incorporated (DGX) key performance indicators and operating metrics (11 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted diluted earnings per share (non-Generally Accepted Accounting Principles) | 2.50 USD_per_share | FY2026-Q1 |
| Consolidated revenue growth (year-over-year) | 9.20 percent | FY2026-Q1 |
| Diagnostic information services revenues | 2.83B | FY2026-Q1 |
| Adjusted operating income (non-Generally Accepted Accounting Principles) | 447M | FY2026-Q1 |
| Organic requisitions volume growth (year-over-year) | 10.90 percent | FY2026-Q1 |
| Adjusted operating margin (adjusted operating income as a percentage of revenue) | 15.40 percent | FY2026-Q1 |
| Revenue per requisition growth (year-over-year) | -1.30 percent | FY2026-Q1 |
| Adjusted net income attributable to Quest Diagnostics (non-Generally Accepted Accounting Principles) | 281M | FY2026-Q1 |
| Adjusted diluted earnings per share growth (year-over-year) | 13.10 percent | FY2026-Q1 |
| Organic requisition volume change | 10.80 percent | FY2026-Q1 |
| Organic revenue growth (year-over-year) | 6.40 percent | FY2025-Q4 |
Back to DGX overview · DGX earnings · DGX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.